GILD - Stifel starts Mirum at buy cites IBATi drug potential
2024-04-18 10:39:58 ET
More on Mirum Pharmaceuticals
- Mirum Pharmaceuticals: Advancing On Several Key Fronts
- Mirum Pharmaceuticals, Inc. (MIRM) Q4 2023 Earnings Call Transcript
- Mirum Pharmaceuticals, Inc. 2023 Q4 - Results - Earnings Call Presentation
- Mirum’s LIVMARLI receives positive reimbursement recommendation by Canada’s CADTH
- Mirum gains as FDA accepts label expansion of liver disease drug